Spelman, T. Et Al. 2024. Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology , vol.102, no.7 .

Spelman, T., Simoneau, G., Hyde, R., Kuhelj, R., Alroughani, R., Ozakbas, S., ... Karabudak, R.(2024). Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study. Neurology , vol.102, no.7.

Spelman, Tim Et Al. "Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study," Neurology , vol.102, no.7, 2024

Spelman, Tim Et Al. "Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study." Neurology , vol.102, no.7, 2024

Spelman, T. Et Al. (2024) . "Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study." Neurology , vol.102, no.7.

@article{article, author={Tim Spelman Et Al. }, title={Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis: A Registry-Based Study}, journal={Neurology}, year=2024}